These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31369420)

  • 21. Prevention of Clostridium difficile Infection With Probiotics.
    Evans CT; Johnson S
    Clin Infect Dis; 2015 May; 60 Suppl 2():S122-8. PubMed ID: 25922397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Probiotics and Fecal Microbiota Transplant for Primary and Secondary Prevention of Clostridium difficile Infection.
    Crow JR; Davis SL; Chaykosky DM; Smith TT; Smith JM
    Pharmacotherapy; 2015 Nov; 35(11):1016-25. PubMed ID: 26598094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
    Mintz M; Khair S; Grewal S; LaComb JF; Park J; Channer B; Rajapakse R; Bucobo JC; Buscaglia JM; Monzur F; Chawla A; Yang J; Robertson CE; Frank DN; Li E
    PLoS One; 2018; 13(1):e0190997. PubMed ID: 29385143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fecal microbiota transplantation for recurrent Clostridioides difficile infection.
    Haber SL; Raney CRK; Larson TL; Lau JP
    Am J Health Syst Pharm; 2019 Jun; 76(13):935-942. PubMed ID: 31361890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clostridioides Difficile: A Concise Review of Best Practices and Updates.
    Yakout A; Bi Y; Harris DM
    J Prim Care Community Health; 2024; 15():21501319241249645. PubMed ID: 38726585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clostridioides difficile Infections: Prevention and Treatment Strategies.
    Levy EI; Dinleyici M; Dinleyici E; Vandenplas Y
    Adv Exp Med Biol; 2024; 1449():175-186. PubMed ID: 39060738
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Asempa TE; Nicolau DP
    Clin Interv Aging; 2017; 12():1799-1809. PubMed ID: 29123385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update of treatment algorithms for Clostridium difficile infection.
    Ooijevaar RE; van Beurden YH; Terveer EM; Goorhuis A; Bauer MP; Keller JJ; Mulder CJJ; Kuijper EJ
    Clin Microbiol Infect; 2018 May; 24(5):452-462. PubMed ID: 29309934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study.
    Ianiro G; Murri R; Sciumè GD; Impagnatiello M; Masucci L; Ford AC; Law GR; Tilg H; Sanguinetti M; Cauda R; Gasbarrini A; Fantoni M; Cammarota G
    Ann Intern Med; 2019 Nov; 171(10):695-702. PubMed ID: 31683278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New and emerging therapies for Clostridium difficile infection.
    Martin J; Wilcox M
    Curr Opin Infect Dis; 2016 Dec; 29(6):546-554. PubMed ID: 27753689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiologic factors affecting Clostridium difficile recurrence.
    Chilton CH; Pickering DS; Freeman J
    Clin Microbiol Infect; 2018 May; 24(5):476-482. PubMed ID: 29208562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Treatment Outcomes for Recurrent Clostridium difficile Infections and Fecal Microbiota Transplantation in a Pediatric Hospital.
    Aldrich AM; Argo T; Koehler TJ; Olivero R
    Pediatr Infect Dis J; 2019 Jan; 38(1):32-36. PubMed ID: 29601446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microbiome therapeutics for the treatment of recurrent
    Bloom PP; Young VB
    Expert Opin Biol Ther; 2023 Jan; 23(1):89-101. PubMed ID: 36536532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Initial experience with fecal microbiota transplantation in Clostridium difficile infection - transplant protocol and preliminary results.
    Ponte A; Pinho R; Mota M; Silva J; Vieira N; Oliveira R; Pinto-Pais T; Fernandes C; Ribeiro I; Rodrigues J; Lopes P; Teixeira T; Carvalho J
    Rev Esp Enferm Dig; 2015 Jul; 107(7):402-7. PubMed ID: 26140631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The potential of microbiome replacement therapies for Clostridium difficile infection.
    Buckley AM; Moura IB; Wilcox MH
    Curr Opin Gastroenterol; 2022 Jan; 38(1):1-6. PubMed ID: 34871192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
    Konturek PC; Koziel J; Dieterich W; Haziri D; Wirtz S; Glowczyk I; Konturek K; Neurath MF; Zopf Y
    J Physiol Pharmacol; 2016 Dec; 67(6):859-866. PubMed ID: 28195066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clostridioides difficile infections; new treatments and future perspectives.
    Normington C; Chilton CH; Buckley AM
    Curr Opin Gastroenterol; 2024 Jan; 40(1):7-13. PubMed ID: 37942659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tackling the recurrence of Clostridium difficile infection.
    Petrosillo N
    Med Mal Infect; 2018 Feb; 48(1):18-22. PubMed ID: 29336928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. My Treatment Approach to Clostridioides difficile Infection.
    Khanna S
    Mayo Clin Proc; 2021 Aug; 96(8):2192-2204. PubMed ID: 34175104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.